It's time to finally put an end to “what the market will bear” as a method of pricing prescription drugs.
Leigh Purvis, MPA
Advertisement
Leigh Purvis is the director of Health Services Research in AARP's Public Policy Institute. She leads a team of policy analysts and researchers who work on healthcare issues that are relevant to the 50 population. In addition, Ms Purvis heads the Institute's work on prescription drug and mental health issues. Her primary areas of expertise are prescription drug pricing, biologic drugs, and prescription drug coverage.
Articles by Leigh Purvis, MPA
Advertisement
Latest Updated Articles
- Are We Finally Ready to Rethink Prescription Drug Pricing?
Published: January 8th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Misinformation and Knowledge Gaps Undermine Vaccine Protection: Kristina Crothers, MD
2
Proactive MG Management Hinges on Better Coverage and Guidelines
3
Provider Shortages, Coverage, Cost Are Top Barriers to Care: CHEST 2025 Experts
4
With New OUD Diagnoses on the Rise, More Comprehensive Screenings Needed
5
